Name: 글로벌 시장 동향
SKU: MD9433
Availability: InStock

보고서 요약(국문)

개요
전 세계 의료 분야 시선 추적 시장은 2024년 8억 287만 달러 규모에 달했으며, 2025년부터 2033년까지 연평균 21.4%의 성장률을 기록하며 2033년에는 51억 5,583만 달러에 이를 것으로 예상됩니다.
전 세계 의료 분야 시선 추적 시장은 시선 추적 기술을 활용하여 진단 도구부터 의료 기기 및 애플리케이션의 사용자 경험 개선에 이르기까지 의료 서비스 제공의 다양한 측면을 향상시키고 있습니다. 시선 추적 기술은 사람의 눈 움직임과 초점을 측정하여 신경학적 평가, 인지 장애 진단 및 재활 치료에 유용한 데이터를 제공합니다.
이 기술은 뇌졸중, 치매, 시력 장애와 같은 질환을 감지하기 위해 눈 움직임을 모니터링하는 데 사용될 뿐만 아니라 ADHD 또는 자폐 스펙트럼 장애와 같은 정신 건강 상태에 대한 통찰력도 제공합니다. 의료 전문가는 환자의 초점 위치와 방식을 추적함으로써 인지 및 신경 건강에 대한 더 깊은 이해를 얻고, 보다 정확한 치료와 진단을 내릴 수 있습니다.

시장 동향: 성장 동력 및 제약 요인
신경 및 인지 장애 유병률 증가
신경 및 인지 장애의 유병률 증가는 전 세계 의료 분야 시선 추적 시장의 주요 성장 동력입니다. 알츠하이머병, 파킨슨병, 뇌졸중, 자폐 스펙트럼 장애(ASD)와 같은 신경 및 인지 질환이 증가함에 따라 시선 추적 기술과 같은 혁신적인 진단 및 모니터링 도구에 대한 수요가 증가하고 있습니다.
시선 추적 기술은 눈 움직임을 분석하여 이러한 질환에 대한 귀중한 통찰력을 제공하고, 초기 징후를 파악하여 보다 정확한 진단을 지원합니다. 예를 들어, 세계보건기구(WHO)는 전 세계적으로 약 5천만 명이 치매를 앓고 있으며, 이 수치는 2030년까지 8천2백만 명으로 증가할 것으로 예상합니다. 또한, 파킨슨병은 전 세계적으로 약 1천만 명에게 영향을 미칩니다. 이러한 수치는 의료 분야에서 더 나은 진단 도구가 시급히 필요함을 보여줍니다.

시선 추적 기술은 신경 기능 평가, 인지 기능의 초기 변화 감지, 그리고 질병 진행 상황을 비침습적으로 모니터링하는 데 중요한 역할을 할 수 있습니다. 전 세계적으로 고령화가 진행되고 인지 장애 발생률이 증가함에 따라, 시선 추적 기술은 환자 치료를 개선하고 치료 결과를 향상시키고자 하는 임상의에게 필수적인 도구가 되고 있습니다. 이러한 모든 요인들이 의료 시장에서 시선 추적 기술의 필요성을 증대시키고 있습니다.
높은 장비 및 구축 비용
높은 장비 및 구축 비용은 의료 분야에서 시선 추적 기술의 광범위한 도입을 저해하는 주요 요인으로 작용하며, 특히 의료 환경에서 더욱 그렇습니다. 시선 추적 시스템, 특히 의료 진단이나 신경학적 평가를 위해 설계된 시스템은 고가의 센서, 특수 소프트웨어, 그리고 고급 하드웨어 구성 요소를 필요로 하기 때문에 가격이 매우 높습니다.
예를 들어, 신경 질환이나 인지 장애와 관련된 미세한 눈 움직임을 감지할 수 있는 임상 등급 시스템은 장비와 이를 지원하는 인프라 모두에 상당한 투자가 필요합니다. 시선 추적 시스템의 가격대가 1,001달러에서 10,000달러에 이르는 것은 전 세계 의료 분야 시선 추적 시장 성장을 저해하는 요인으로 작용할 수 있습니다. 이러한 시스템은 특정 용도에는 적합하지만, 보다 정밀한 의료 진단에 필요한 정밀도와 신뢰성 기준을 충족하지 못할 수 있기 때문입니다. 따라서 이러한 요인들이 전 세계 의료 분야 시선 추적 시장의 잠재적 성장을 제한할 수 있습니다.
세분화 분석
전 세계 의료 분야 시선 추적 시장은 유형, 추적 방식, 구성 요소, 응용 분야, 최종 사용자 및 지역별로 세분화됩니다.
추적 방식:
추적 방식 중 원격 추적 방식이 가장 높은 시장 점유율을 차지하며 전 세계 의료 분야 시선 추적 시장을 주도할 것으로 예상됩니다.
원격 추적 방식은 클라우드 컴퓨팅, 모바일 기기, 웨어러블 기기 등의 혁신적인 기술을 활용하여 기존 임상 환경 밖에서도 환자의 시선 움직임을 모니터링할 수 있도록 합니다.
이러한 기능은 원격 의료 플랫폼, 모바일 건강 앱, 가정 기반 모니터링 시스템에 매우 중요합니다. 원격 시선 추적 기술은 의료진이 환자를 원거리에서 추적할 수 있도록 함으로써 신경계 질환, 인지 장애 또는 재활 치료를 받는 환자를 지속적으로 모니터링하는 데 특히 유용합니다.
이 기술은 환자가 의료 시설을 정기적으로 방문해야 하는 필요성을 없애 의료 접근성을 개선하고 환자의 편의성을 향상시킵니다. 특히 만성 질환 환자의 경우 증상 변동이 심해 지속적인 추적이 필요할 수 있으므로 이러한 편의성 향상은 매우 중요합니다.
원격 추적 기술은 의료 환경 외부에서도 시선 움직임을 분석할 수 있도록 함으로써 환자 치료에 더 큰 유연성을 제공하고 인지 또는 신경 건강 변화를 조기에 감지할 수 있도록 지원합니다. 또한 실시간 데이터 수집이 가능하여 즉각적인 정보를 바탕으로 치료 계획이나 개입을 쉽게 조정할 수 있습니다. 이러한 요소들은 전 세계 의료 분야 시선 추적 시장에서 해당 분야의 입지를 강화했습니다.
지역 분석
북미는 전 세계 의료 분야 시선 추적 시장에서 가장 높은 시장 점유율을 차지하며 중요한 위치를 차지할 것으로 예상됩니다.
북미 의료 분야 시선 추적 시장은 여러 요인에 의해 성장하고 있습니다. 주요 성장 동력 중 하나는 의료 분야, 특히 파킨슨병, 알츠하이머병 및 기타 인지 장애와 같은 신경계 질환의 진단 및 모니터링에 있어 시선 추적 기술의 적용이 증가하고 있다는 점입니다. 이 기술은 눈의 움직임과 시선 패턴에 대한 귀중한 정보를 제공하여 조기 발견 및 평가에 도움을 주고 치료 및 재활의 효과를 높입니다.
또한 북미 지역의 선진 의료 시스템과 기술 인프라는 시장 성장을 견인하는 데 중요한 역할을 합니다. 이 지역에는 시선 추적 기술을 인지 재활 및 중증 운동 장애 환자를 위한 보조 기기 개발 등 임상 현장에 통합하는 선도적인 연구 기관과 의료 서비스 제공업체가 있습니다.
이 지역에서는 소비자 가전, 게임 및 자동차 산업에서도 시선 추적 기술의 도입이 증가하고 있으며, 이러한 모든 분야가 의료 환경에서 시선 추적 기술의 활용 범위를 넓히는 데 기여하고 있습니다. 따라서 이러한 요인들이 복합적으로 작용하여 북미 지역은 글로벌 의료 분야 시선 추적 시장에서 주도적인 위치를 차지하고 있습니다.

경쟁 환경
의료 분야 시선 추적 시장의 주요 글로벌 업체로는 Tobii, SR Research Ltd., iMotions, Gazepoint, EyeTech Digital Systems, Inc., Pupil Labs GmbH, EyeTracking, Smart Eye, Lumen, ERGONEERS GmbH 등이 있습니다.
주요 개발 사항
• 2024년 2월, Visage Imaging, Inc.는 Apple의 기대작 공간 컴퓨팅 플랫폼인 Apple Vision Pro용 혁신적인 Visage Ease VP를 공개했습니다. Apple Vision Pro의 고유한 기능을 활용하도록 맞춤 설계된 Visage Ease VP는 진단 영상 및 멀티미디어 애플리케이션을 위한 몰입형 공간 상호 작용을 지원합니다.

• 2024년 1월, Tobii는 시선 추적 기술을 활용하여 모바일 사용자 경험(UX) 연구를 강화하도록 설계된 클라우드 플랫폼 UX Explore를 출시했습니다. 이는 글로벌 의료 분야 시선 추적 시장에 긍정적인 영향을 미칠 수 있는 중요한 개발입니다. 이 클라우드 기반 솔루션은 확장성, 효율성, 접근성을 향상시킨 UX 연구를 지원하여 의료 전문가와 개발자가 모바일 의료 애플리케이션, 원격 의료 플랫폼, 디지털 건강 기기의 사용자 경험을 더욱 쉽게 평가할 수 있도록 합니다.
보고서 구매 이유:

• 파이프라인 및 혁신: 진행 중인 임상 시험 및 제품 파이프라인을 검토하고 의료 기기 및 의약품의 향후 발전을 예측합니다.

• 제품 성능 및 시장 포지셔닝: 제품 성능, 시장 포지셔닝 및 성장 잠재력을 분석하여 전략을 최적화합니다.

• 실제 임상 데이터: 환자 피드백 및 데이터를 제품 개발에 통합하여 결과를 개선합니다.

• 의사 선호도 및 의료 시스템 영향: 의료 서비스 제공자의 행동과 의료 시스템 합병이 도입 전략에 미치는 영향을 분석합니다.

• 시장 업데이트 및 산업 변화: 최근 규제 변화, 새로운 정책 및 신기술을 다룹니다.

• 경쟁 전략: 경쟁사 전략, 시장 점유율 및 신흥 기업을 분석합니다.

• 가격 책정 및 시장 접근: 가격 모델, 상환 동향 및 시장 접근 전략을 검토합니다.

• 시장 진입 및 확장: 신규 시장 진출 및 파트너십을 위한 최적의 전략을 제시합니다.

• 지역 성장 및 투자: 고성장 지역과 투자 기회를 중점적으로 분석합니다.

• 공급망 최적화: 효율적인 제품 공급을 위한 공급망 위험 및 유통 전략을 평가합니다.

• 지속가능성 및 규제 영향: 친환경적인 관행과 의료 분야의 변화하는 규제에 초점을 맞춥니다.

• 시판 후 감시: 시판 후 데이터를 활용하여 제품 안전성과 접근성을 향상시킵니다.

• 약물경제학 및 가치 기반 가격 책정: 가치 기반 가격 책정 및 데이터 기반 의사결정으로의 전환을 분석합니다.
이 글로벌 의료 시장 보고서는 78개의 핵심 표, 71개 이상의 시각적으로 효과적인 그림, 그리고 176페이지 분량의 전문가 분석을 통해 시장 현황을 종합적으로 보여줍니다.
2024년 주요 고객
• 제조업체: 제약, 의료기기, 바이오테크 기업, 위탁 제조업체, 유통업체, 병원

• 규제 및 정책: 규정 준수 담당자, 정부 관계자, 보건 경제학자, 시장 진출 전문가

• 기술 및 혁신: AI/로봇 기술 제공업체, 연구 개발 전문가, 임상 시험 관리자, 약물감시 전문가

• 투자자: 의료 투자자, 벤처 펀드 투자자, 제약 마케팅 및 영업 담당자

• 컨설팅 및 자문: 의료 컨설턴트, 산업 협회, 분석가

• 공급망: 유통 및 공급망 관리자

• 소비자 및 옹호: 환자, 옹호 단체, 보험 회사

• 학술 및 연구: 연구 기관

보고서 요약(영어 원문)

Overview
The global eye tracking in healthcare market reached US$ 802.87 million in 2024 and is expected to reach US$ 5,155.83 million by 2033, growing at a CAGR of 21.4 % during the forecast period of 2025-2033.
The global eye tracking in healthcare market leverages eye tracking technology to enhance various aspects of healthcare delivery, ranging from diagnostic tools to improving the user experience in medical devices and applications. Eye tracking measures the movement and focus of a person’s eyes, providing valuable data for neurological assessments, cognitive disorder diagnoses, and rehabilitation therapy.
This technology is used to monitor eye movements for the detection of conditions such as stroke, dementia, and visual impairments, while also offering insights into mental health conditions like ADHD or autism spectrum disorders. By tracking where and how patients focus, healthcare professionals gain a deeper understanding of cognitive and neurological health, leading to more precise treatments and diagnoses.
Market Dynamics: Drivers & Restraints
Rising Prevalence of Neurological and Cognitive Disorders
The rising prevalence of neurological and cognitive disorders is a key driver in the global eye tracking in healthcare market. As neurological and cognitive conditions such as Alzheimer’s disease, Parkinson’s disease, stroke, and autism spectrum disorders (ASD) become more common, the demand for innovative diagnostic and monitoring tools, such as eye tracking technology, is increasing.
Eye tracking offers valuable insights into these disorders by analyzing eye movements, helping to identify early signs and aiding in more accurate diagnoses. For instance, the World Health Organization estimates that approximately 50 million people worldwide suffer from dementia, and the number is expected to rise to 82 million by 2030. Additionally, Parkinson’s disease affects about 10 million people globally. These numbers underscore the urgent need for better diagnostic tools in the healthcare sector.
Eye tracking can play a critical role in assessing neurological function, detecting early changes in cognition, and offering a non-invasive way to monitor disease progression over time. As the global population ages and the incidence of cognitive disorders increases, eye tracking technology is becoming an essential tool for clinicians aiming to improve patient care and enhance treatment outcomes. All these factors demand global eye tracking in the healthcare market.
High Costs of Equipment and Implementation
The high costs of equipment and implementation pose a significant restraint in the global eye tracking in healthcare market, limiting the widespread adoption of this technology, especially in healthcare settings. Eye tracking systems, particularly those designed for medical diagnostics or neurological assessments, often involve high-end sensors, specialized software, and advanced hardware components that come at a steep price.
For instance, clinical-grade systems capable of detecting subtle eye movements associated with neurological diseases or cognitive disorders require significant investment in both equipment and the infrastructure to support them. The price range of $1.001 to $10,000 for eye tracking systems can act as a restraint in the global eye tracking in healthcare market because these systems, while suitable for certain applications, may not meet the precision and reliability standards required for more advanced healthcare diagnostics. Thus, the above factors could be limiting the global eye tracking in the healthcare market's potential growth.
Segment Analysis
The global eye tracking in healthcare market is segmented based on type, tracking type, component, application, end-user, and region.
Tracking Type:
The remote tracking segment in tracking type is expected to dominate the global eye tracking in healthcare market with the highest market share
The remote tracking segment of the global eye tracking in healthcare market leverages innovative technologies such as cloud computing, mobile devices, and wearable technologies to enable the monitoring of patients' eye movements outside traditional clinical settings.
This capability is crucial in telemedicine platforms, mobile health apps, and home-based monitoring systems. By allowing healthcare providers to track patients from a distance, remote eye tracking can be especially beneficial for continuous monitoring of those with neurological conditions, cognitive disorders, or individuals undergoing rehabilitation therapies.
It eliminates the need for patients to visit healthcare facilities regularly, improving access to care and enhancing patient convenience. This is especially important as patients, particularly those with chronic conditions, can experience fluctuations in symptoms that require consistent tracking.
By enabling eye movement analysis outside of medical environments, remote tracking technology offers greater flexibility in patient care and supports early detection of changes in cognitive or neurological health. It also allows for real-time data collection, making it easier to adjust treatment plans or interventions based on immediate insights. These factors have solidified the segment's position in the global eye tracking in healthcare market.
Geographical Analysis
North America is expected to hold a significant position in the global eye tracking in healthcare market, with the highest market share
The North American eye tracking in healthcare market is being driven by several factors. One of the key drivers is the increasing application of eye tracking technology in the healthcare sector, particularly for diagnosing and monitoring neurological disorders like Parkinson’s disease, Alzheimer’s, and other cognitive impairments. This technology provides valuable insights into eye movements and gaze patterns, which help in early detection and assessment, enhancing the effectiveness of treatment and rehabilitation.
Furthermore, North America’s advanced healthcare system and technological infrastructure play a significant role in driving the market. The region is home to leading research institutions and healthcare providers that integrate eye tracking into clinical practices, such as in cognitive rehabilitation and assistive devices for patients with severe motor disabilities.
The region is also seeing increased adoption in consumer electronics, gaming, and the automotive industry, all of which are contributing to the broader use of eye tracking in healthcare settings. Thus, the above factors are consolidating the region's position as a dominant force in the global eye tracking in healthcare market.
Competitive Landscape
The major global players in the eye tracking in healthcare market include Tobii, SR Research Ltd., iMotions, Gazepoint, EyeTech Digital Systems, Inc., Pupil Labs GmbH, EyeTracking, Smart Eye, Lumen, and ERGONEERS GmbH, among others.
Key Developments
• In February 2024, Visage Imaging, Inc. unveiled the innovative Visage Ease VP for Apple Vision Pro, Apple’s much-awaited spatial computing platform. Tailored to leverage the distinct features of Apple Vision Pro, Visage Ease VP enables immersive, spatial interactions for diagnostic imaging and multimedia applications.
• In January 2024, Tobii's launch of the UX Explore cloud platform, designed to enhance mobile user experience (UX) research with eye-tracking technology, is a significant development that could positively impact the global eye-tracking in healthcare market. This cloud-based solution allows for more scalable, efficient, and accessible UX research, enabling healthcare professionals and developers to evaluate the user experience of mobile healthcare applications, telemedicine platforms, and digital health devices with greater ease.
Why Purchase the Report?
• Pipeline & Innovations: Reviews ongoing clinical trials and product pipelines and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzed product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.
The global eye tracking in healthcare market report delivers a detailed analysis with 78 key tables, more than 71 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.
Target Audience 2024
• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.

• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.

• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.

• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.

• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.

• Supply Chain: Distribution and Supply Chain Managers.

• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.

• Academic & Research: Academic Institutions.

상세 목차

1. Market Introduction and Scope
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. Executive Insights and Key Takeaways
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Type
2.4. Snippet by Tracking Type
2.5. Snippet by Component
2.6. Snippet by Application
2.7. Snippet by End-User
2.8. Snippet by Region
3. Dynamics
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Rising Prevalence of Neurological and Cognitive Disorders
3.1.1.2. Advancements in Eye Tracking Technology
3.1.1.3. XX
3.1.2. Restraints
3.1.2.1. High Costs of Equipment and Implementation
3.1.2.2. Privacy and Data Security Concerns
3.1.2.3. XX
3.1.3. Opportunity
3.1.3.1. Integration with Virtual Reality (VR) and Augmented Reality (AR)
3.1.3.2. XX
3.1.4. Impact Analysis
4. Strategic Insights and Industry Outlook
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established leaders with the largest-selling Brand
4.1.3. Market leaders with established Product
4.2. CXO Perspectives
4.3. Latest Developments and Breakthroughs
4.4. Case Studies/Ongoing Research
4.5. Regulatory and Reimbursement Landscape
4.5.1. North America
4.5.2. Europe
4.5.3. Asia Pacific
4.5.4. Latin America
4.5.5. Middle East & Africa
4.6. Porter’s Five Forces Analysis
4.7. Supply Chain Analysis
4.8. Patent Analysis
4.9. SWOT Analysis
4.10. Unmet Needs and Gaps
4.11. Recommended Strategies for Market Entry and Expansion
4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
4.13. Pricing Analysis and Price Dynamics
4.14. Key Opinion Leaders
5. Eye Tracking in Healthcare Market, By Type
5.1. Introduction
5.1.1. Analysis and Y-o-Y Growth Analysis (%), By Type
5.1.2. Market Attractiveness Index, By Type
5.2. Electrooculography (EOG)*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.2.3. Tracking
5.3. Optical Tracking
5.4. Eye-Attached Tracking
6. Eye Tracking in Healthcare Market, By Tracking Type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tracking Type
6.1.2. Market Attractiveness Index, By Tracking Type
6.2. Remote Tracking*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Mobile Tracking
7. Eye Tracking in Healthcare Market, By Component
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
7.1.2. Market Attractiveness Index, By Component
7.2. Hardware*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Software
8. Eye Tracking in Healthcare Market, By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Medical Research & Diagnostics*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Assistive Technology
8.4. Cognitive & Neurological Studies
8.5. Ophthalmology & Vision Science
9. Eye Tracking in Healthcare Market, By End-User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Healthcare Providers*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Research Institutes
9.4. Assistive Device Manufacturers
10. Eye Tracking in Healthcare Market, By Regional Market Analysis and Growth Opportunities
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tracking Type
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.8.1. U.S.
10.2.8.2. Canada
10.2.8.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tracking Type
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.8.1. Germany
10.3.8.2. U.K.
10.3.8.3. France
10.3.8.4. Spain
10.3.8.5. Italy
10.3.8.6. Rest of Europe
10.4. Latin America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tracking Type
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.8.1. Brazil
10.4.8.2. Argentina
10.4.8.3. Rest of Latin America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tracking Type
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.8.1. China
10.5.8.2. India
10.5.8.3. Japan
10.5.8.4. South Korea
10.5.8.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Tracking Type
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. Competitive Landscape and Market Positioning
11.1. Competitive Overview and Key Market Players
11.2. Market Share Analysis and Positioning Matrix
11.3. Strategic Partnerships, Mergers & Acquisitions
11.4. Key Developments in Product Portfolios and Innovations
11.5. Company Benchmarking
12. Company Profiles
12.1. Tobii*
12.1.1. Company Overview
12.1.2. Product Portfolio
12.1.2.1. Product Description
12.1.2.2. Product Key Performance Indicators (KPIs)
12.1.2.3. Historic and Forecasted Product Sales
12.1.2.4. Product Sales Volume
12.1.3. Financial Overview
12.1.3.1. Company Revenue
12.1.3.2. Geographical Revenue Shares
12.1.3.3. Revenue Forecasts
12.1.4. Key Developments
12.1.4.1. Mergers & Acquisitions
12.1.4.2. Key Product Development Activities
12.1.4.3. Regulatory Approvals, etc.
12.1.5. SWOT Analysis
12.2. SR Research Ltd.
12.3. iMotions
12.4. Gazepoint
12.5. EyeTech Digital Systems, Inc.
12.6. Pupil Labs GmbH.
12.7. EyeTracking
12.8. Smart Eye
12.9. Lumen
12.10. ERGONEERS GmbH
LIST NOT EXHAUSTIVE
13. Assumptions and Research Methodology
13.1. Data Collection Methods
13.2. Data Triangulation
13.3. Forecasting Techniques
13.4. Data Verification and Validation
14. Appendix
14.1. About Us and Services
14.2. Contact Us

언급된 주요 기업들

Tobii, 2.1.	Product Description, 2.2.	Product Key Performance Indicators (KPIs), 2.3.	Historic and Forecasted Product Sales, 2.4.	Product Sales Volume, 3.1.	Company Revenue, 3.2.	Geographical Revenue Shares, 3.3.	Revenue Forecasts, 4.	Key Developments, 4.1.	Mergers & Acquisitions, 4.2.	Key Product Development Activities, 4.3.	Regulatory Approvals, etc., 5.	SWOT Analysis, SR Research Ltd., iMotions, Gazepoint, EyeTech Digital Systems, Inc., Pupil Labs GmbH., EyeTracking, Smart Eye, Lumen, ERGONEERS GmbH

표 목록 (Tables)

List of Tables

Table 1 Global Eye Tracking in Healthcare Market Value, By Type, 2025, 2029 & 2033 (US$ Million)

Table 2 Global Eye Tracking in Healthcare Market Value, By Tracking Type, 2025, 2029 & 2033 (US$ Million)

Table 3 Global Eye Tracking in Healthcare Market Value, By Component, 2025, 2029 & 2033 (US$ Million)

Table 4 Global Eye Tracking in Healthcare Market Value, By Application, 2025, 2029 & 2033 (US$ Million)

Table 5 Global Eye Tracking in Healthcare Market Value, By End-User, 2025, 2029 & 2033 (US$ Million)

Table 6 Global Eye Tracking in Healthcare Market Value, By Region, 2025, 2029 & 2033 (US$ Million)

Table 7 Global Eye Tracking in Healthcare Market Value, By Type, 2025, 2029 & 2033 (US$ Million)

Table 8 Global Eye Tracking in Healthcare Market Value, By Type, 2022-2033 (US$ Million)

Table 9 Global Eye Tracking in Healthcare Market Value, By Tracking Type, 2025, 2029 & 2033 (US$ Million)

Table 10 Global Eye Tracking in Healthcare Market Value, By Tracking Type, 2022-2033 (US$ Million)

Table 11 Global Eye Tracking in Healthcare Market Value, By Component, 2025, 2029 & 2033 (US$ Million)

Table 12 Global Eye Tracking in Healthcare Market Value, By Component, 2022-2033 (US$ Million)

Table 13 Global Eye Tracking in Healthcare Market Value, By Application, 2025, 2029 & 2033 (US$ Million)

Table 14 Global Eye Tracking in Healthcare Market Value, By Application, 2022-2033 (US$ Million)

Table 15 Global Eye Tracking in Healthcare Market Value, By End-User, 2025, 2029 & 2033 (US$ Million)

Table 16 Global Eye Tracking in Healthcare Market Value, By End-User, 2022-2033 (US$ Million)

Table 17 Global Eye Tracking in Healthcare Market Value, By Region, 2025, 2029 & 2033 (US$ Million)

Table 18 Global Eye Tracking in Healthcare Market Value, By Region, 2022-2033 (US$ Million)

Table 19 North America Eye Tracking in Healthcare Market Value, By Type, 2022-2033 (US$ Million)

Table 20 North America Eye Tracking in Healthcare Market Value, By Tracking Type, 2022-2033 (US$ Million)

Table 21 North America Eye Tracking in Healthcare Market Value, By Component, 2022-2033 (US$ Million)

Table 22 North America Eye Tracking in Healthcare Market Value, By Application, 2022-2033 (US$ Million)

Table 23 North America Eye Tracking in Healthcare Market Value, By End-User, 2022-2033 (US$ Million)

Table 24 North America Eye Tracking in Healthcare Market Value, By Country, 2022-2033 (US$ Million)

Table 25 Latin America Eye Tracking in Healthcare Market Value, By Type, 2022-2033 (US$ Million)

Table 26 Latin America Eye Tracking in Healthcare Market Value, By Tracking Type, 2022-2033 (US$ Million)

Table 27 Latin America Eye Tracking in Healthcare Market Value, By Component, 2022-2033 (US$ Million)

Table 28 Latin America Eye Tracking in Healthcare Market Value, By Application, 2022-2033 (US$ Million)

Table 29 Latin America Eye Tracking in Healthcare Market Value, By End-User, 2022-2033 (US$ Million)

Table 30 Latin America Eye Tracking in Healthcare Market Value, By Country, 2022-2033 (US$ Million)

Table 31 Europe Eye Tracking in Healthcare Market Value, By Type, 2022-2033 (US$ Million)

Table 32 Europe Eye Tracking in Healthcare Market Value, By Tracking Type, 2022-2033 (US$ Million)

Table 33 Europe Eye Tracking in Healthcare Market Value, By Component, 2022-2033 (US$ Million)

Table 34 Europe Eye Tracking in Healthcare Market Value, By Application, 2022-2033 (US$ Million)

Table 35 Europe Eye Tracking in Healthcare Market Value, By End-User, 2022-2033 (US$ Million)

Table 36 Europe Eye Tracking in Healthcare Market Value, By Country, 2022-2033 (US$ Million)

Table 37 Asia-Pacific Eye Tracking in Healthcare Market Value, By Type, 2022-2033 (US$ Million)

Table 38 Asia-Pacific Eye Tracking in Healthcare Market Value, By Tracking Type, 2022-2033 (US$ Million)

Table 39 Asia-Pacific Eye Tracking in Healthcare Market Value, By Component, 2022-2033 (US$ Million)

Table 40 Asia-Pacific Eye Tracking in Healthcare Market Value, By Application, 2022-2033 (US$ Million)

Table 41 Asia-Pacific Eye Tracking in Healthcare Market Value, By End-User, 2022-2033 (US$ Million)

Table 42 Asia-Pacific Eye Tracking in Healthcare Market Value, By Country, 2022-2033 (US$ Million)

Table 43 Middle East and Africa Eye Tracking in Healthcare Market Value, By Type, 2022-2033 (US$ Million)

Table 44 Middle East and Africa Eye Tracking in Healthcare Market Value, By Tracking Type, 2022-2033 (US$ Million)

Table 45 Middle East and Africa Eye Tracking in Healthcare Market Value, By Component, 2022-2033 (US$ Million)

Table 46 Middle East and Africa Eye Tracking in Healthcare Market Value, By Application, 2022-2033 (US$ Million)

Table 47 Middle East and Africa Eye Tracking in Healthcare Market Value, By End-User, 2022-2033 (US$ Million)

Table 48 Middle East and Africa Eye Tracking in Healthcare Market Value, By Country, 2022-2033 (US$ Million)

Table 49 Tobii: Overview

Table 50 Tobii: Product Portfolio

Table 51 Tobii: Key Developments

Table 52 SR Research Ltd.: Overview

Table 53 SR Research Ltd.: Product Portfolio

Table 54 SR Research Ltd.: Key Developments

Table 55 iMotions: Overview

Table 56 iMotions: Product Portfolio

Table 57 iMotions: Key Developments

Table 58 Gazepoint: Overview

Table 59 Gazepoint: Product Portfolio

Table 60 Gazepoint: Key Developments

Table 61 EyeTech Digital Systems, Inc.: Overview

Table 62 EyeTech Digital Systems, Inc.: Product Portfolio

Table 63 EyeTech Digital Systems, Inc.: Key Developments

Table 64 Pupil Labs GmbH.: Overview

Table 65 Pupil Labs GmbH.: Product Portfolio

Table 66 Pupil Labs GmbH.: Key Developments

Table 67 EyeTracking: Overview

Table 68 EyeTracking: Product Portfolio

Table 69 EyeTracking: Key Developments

Table 70 Smart Eye: Overview

Table 71 Smart Eye: Product Portfolio

Table 72 Smart Eye: Key Developments

Table 73 Lumen: Overview

Table 74 Lumen: Product Portfolio

Table 75 Lumen: Key Developments

Table 76 ERGONEERS GmbH: Overview

Table 77 ERGONEERS GmbH: Product Portfolio

Table 78 ERGONEERS GmbH: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Eye Tracking in Healthcare Market Value, 2022-2033 (US$ Million)

Figure 2 Global Eye Tracking in Healthcare Market Share, By Type, 2024 & 2033 (%)

Figure 3 Global Eye Tracking in Healthcare Market Share, By Tracking Type, 2024 & 2033 (%)

Figure 4 Global Eye Tracking in Healthcare Market Share, By Component, 2024 & 2033 (%)

Figure 5 Global Eye Tracking in Healthcare Market Share, By Application, 2024 & 2033 (%)

Figure 6 Global Eye Tracking in Healthcare Market Share, By End-User, 2024 & 2033 (%)

Figure 7 Global Eye Tracking in Healthcare Market Share, By Region, 2024 & 2033 (%)

Figure 8 Global Eye Tracking in Healthcare Market Y-o-Y Growth, By Type, 2023-2033 (%)

Figure 9 Electrooculography (EOG) Eye Tracking in Healthcare Market Value, 2022-2033 (US$ Million)

Figure 10 Optical Tracking Eye Tracking in Healthcare Market Value, 2022-2033 (US$ Million)

Figure 11 Eye-Attached Tracking Eye Tracking in Healthcare Market Value, 2022-2033 (US$ Million)

Figure 12 Global Eye Tracking in Healthcare Market Y-o-Y Growth, By Tracking Type, 2023-2033 (%)

Figure 13 Remote Tracking Tracking Type in Global Eye Tracking in Healthcare Market Value, 2022-2033 (US$ Million)

Figure 14 Mobile Tracking Type in Global Eye Tracking in Healthcare Market Value, 2022-2033 (US$ Million)

Figure 15 Global Eye Tracking in Healthcare Market Y-o-Y Growth, By Component, 2023-2033 (%)

Figure 16 Hardware Component in Global Eye Tracking in Healthcare Market Value, 2022-2033 (US$ Million)

Figure 17 Software Component in Global Eye Tracking in Healthcare Market Value, 2022-2033 (US$ Million)

Figure 18 Global Eye Tracking in Healthcare Market Y-o-Y Growth, By Application, 2023-2033 (%)

Figure 19 Medical Research & Diagnostics Application in Global Eye Tracking in Healthcare Market Value, 2022-2033 (US$ Million)

Figure 20 Assistive Technology Application in Global Eye Tracking in Healthcare Market Value, 2022-2033 (US$ Million)

Figure 21 Cognitive & Neurological Studies Application in Global Eye Tracking in Healthcare Market Value, 2022-2033 (US$ Million)

Figure 22 Ophthalmology & Vision Science Application in Global Eye Tracking in Healthcare Market Value, 2022-2033 (US$ Million)

Figure 23 Global Eye Tracking in Healthcare Market Y-o-Y Growth, By End-User, 2023-2033 (%)

Figure 24 Healthcare Providers End-User in Global Eye Tracking in Healthcare Market Value, 2022-2033 (US$ Million)

Figure 25 Research Institutes End-User in Global Eye Tracking in Healthcare Market Value, 2022-2033 (US$ Million)

Figure 26 Assistive Device Manufacturers End-User in Global Eye Tracking in Healthcare Market Value, 2022-2033 (US$ Million)

Figure 27 Global Eye Tracking in Healthcare Market Y-o-Y Growth, By Region, 2023-2033 (%)

Figure 28 North America Eye Tracking in Healthcare Market Value, 2022-2033 (US$ Million)

Figure 29 North America Eye Tracking in Healthcare Market Share, By Type, 2024 & 2033 (%)

Figure 30 North America Eye Tracking in Healthcare Market Share, By Tracking Type, 2024 & 2033 (%)

Figure 31 North America Eye Tracking in Healthcare Market Share, By Component, 2024 & 2033 (%)

Figure 32 North America Eye Tracking in Healthcare Market Share, By Application, 2024 & 2033 (%)

Figure 33 North America Eye Tracking in Healthcare Market Share, By End-User, 2024 & 2033 (%)

Figure 34 North America Eye Tracking in Healthcare Market Share, By Country, 2024 & 2033 (%)

Figure 35 Latin America Eye Tracking in Healthcare Market Value, 2022-2033 (US$ Million)

Figure 36 Latin America Eye Tracking in Healthcare Market Share, By Type, 2024 & 2033 (%)

Figure 37 Latin America Eye Tracking in Healthcare Market Share, By Tracking Type, 2024 & 2033 (%)

Figure 38 Latin America Eye Tracking in Healthcare Market Share, By Component, 2024 & 2033 (%)

Figure 39 Latin America Eye Tracking in Healthcare Market Share, By Application, 2024 & 2033 (%)

Figure 40 Latin America Eye Tracking in Healthcare Market Share, By End-User, 2024 & 2033 (%)

Figure 41 Latin America Eye Tracking in Healthcare Market Share, By Country, 2024 & 2033 (%)

Figure 42 Europe Eye Tracking in Healthcare Market Value, 2022-2033 (US$ Million)

Figure 43 Europe Eye Tracking in Healthcare Market Share, By Type, 2024 & 2033 (%)

Figure 44 Europe Eye Tracking in Healthcare Market Share, By Tracking Type, 2024 & 2033 (%)

Figure 45 Europe Eye Tracking in Healthcare Market Share, By Component, 2024 & 2033 (%)

Figure 46 Europe Eye Tracking in Healthcare Market Share, By Application, 2024 & 2033 (%)

Figure 47 Europe Eye Tracking in Healthcare Market Share, By End-User, 2024 & 2033 (%)

Figure 48 Europe Eye Tracking in Healthcare Market Share, By Country, 2024 & 2033 (%)

Figure 49 Asia-Pacific Eye Tracking in Healthcare Market Value, 2022-2033 (US$ Million)

Figure 50 Asia-Pacific Eye Tracking in Healthcare Market Share, By Type, 2024 & 2033 (%)

Figure 51 Asia-Pacific Eye Tracking in Healthcare Market Share, By Tracking Type, 2024 & 2033 (%)

Figure 52 Asia-Pacific Eye Tracking in Healthcare Market Share, By Component, 2024 & 2033 (%)

Figure 53 Asia-Pacific Eye Tracking in Healthcare Market Share, By Application, 2024 & 2033 (%)

Figure 54 Asia-Pacific Eye Tracking in Healthcare Market Share, By End-User, 2024 & 2033 (%)

Figure 55 Asia-Pacific Eye Tracking in Healthcare Market Share, By Country, 2024 & 2033 (%)

Figure 56 Middle East and Africa Eye Tracking in Healthcare Market Value, 2022-2033 (US$ Million)

Figure 57 Middle East and Africa Eye Tracking in Healthcare Market Share, By Type, 2024 & 2033 (%)

Figure 58 Middle East and Africa Eye Tracking in Healthcare Market Share, By Tracking Type, 2024 & 2033 (%)

Figure 59 Middle East and Africa Eye Tracking in Healthcare Market Share, By Component, 2024 & 2033 (%)

Figure 60 Middle East and Africa Eye Tracking in Healthcare Market Share, By Application, 2024 & 2033 (%)

Figure 61 Middle East and Africa Eye Tracking in Healthcare Market Share, By End-User, 2024 & 2033 (%)

Figure 62 Tobii: Financials

Figure 63 SR Research Ltd.: Financials

Figure 64 iMotions: Financials

Figure 65 Gazepoint: Financials

Figure 66 EyeTech Digital Systems, Inc.: Financials

Figure 67 Pupil Labs GmbH.: Financials

Figure 68 EyeTracking: Financials

Figure 69 Smart Eye: Financials

Figure 70 Lumen: Financials

Figure 71 ERGONEERS GmbH: Financials

글로벌 의료 분야 시선 추적 시장 – 2025-2033년

Global Eye Tracking in Healthcare Market - 2025-2033